Advertisement.

RUBY Projected Dividend Yield

Rubius Therapeutics Inc ( OTCBB : RUBY )

Rubius Therapeutics is a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to develop a class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases. Co.'s platform, RED PLATFORM, biologically engineers and cultures allogeneic red blood cell therapies that enable multiple applications, or modalities. Co.'s immune stimulation for the treatment of cancer includes RTX-240, which is designed to stimulate the immune system by activating and expanding both NK and CD8+ memory T cells to generate an anti-tumor response; and RTX-224, which is designed as an immune agonist of both adaptive and innate responses.

11 YEAR PERFORMANCE RESULTS

RUBY Dividend History Detail
RUBY Dividend News
RUBY Competitors News

# of Shares: 0

Closing Price: 0.06

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.06	0%	0	$ 0.00	0.00%
2026	0.06	0%	0	$ 0.00	0.00%
2027	0.06	0%	0	$ 0.00	0.00%
2028	0.06	0%	0	$ 0.00	0.00%
2029	0.06	0%	0	$ 0.00	0.00%
2030	0.06	0%	0	$ 0.00	0.00%
2031	0.06	0%	0	$ 0.00	0.00%
2032	0.06	0%	0	$ 0.00	0.00%
2033	0.06	0%	0	$ 0.00	0.00%
2034	0.06	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.06 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.06 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2023	Dec 22, 2023	Jan 02, 2024	Dec 26, 2023	Dec 29, 2023	0.0579
2023 Total:					0.0579